A homozygous loss-of-function mutation in FBXO43 causes human non-obstructive azoospermia
A homozygous loss-of-function mutation in FBXO43 causes human non-obstructive azoospermia
复制标题
FBXO43 纯合性功能丧失突变导致人类非梗阻性无精症
DOI:
10.1111/cge.14069
复制
发表时间:
2022
影响因子:
3.5
通讯作者:
Liu Mingxi
中科院分区:
文献类型:
--
作者:
Wu Huan;Zhang Xin;Shen Qunshan;Liu Yiyuan;Gao Yang;Wang Guanxiong;Lv Mingrong;Hua Rong;Xu Yuping;Zhou Ping;Wei Zhaolian;Tao Fangbiao;He Xiaojin;Cao Yunxia;Liu Mingxi
Non‐obstructive azoospermia (NOA) represents one of the most serious forms of male infertility caused by spermatogenic failure. Despite multiple genes found to be associated with human NOA, the genetic basis of this idiopathic disease remains largely unknown. FBXO43 is a direct inhibitor of the anaphase‐promoting complex/cyclosome (APC/C) E3 ligase and crucially important in mouse spermatogenesis. In this study, for the first time, we identified a homozygous nonsense mutation inFBXO43c.1747C > T:p.Gln583X in two NOA brothers from a Chinese consanguineous family via whole‐exome sequencing. FBXO43 was absent from testicular tissue of the proband, and FBXO43‐immunostaining signals were invisible in the affected seminiferous tubules. Furthermore, in humans, FBXO43 defects cause meiotic arrest within early diplotene of prophase I. The results here demonstrate the pathogenicity of this loss‐of‐function mutation and confirmed that spermatocytes were unable to complete meiotic divisions without FBXO43 in humans. In mouse testicular protein extracts, three subunits of the APC/C, including ANAPC2, ANAPC8 and ANAPC10, were validated to interact directly with FBXO43, whereas no interactions were detected for FBXO43 and SKP1. This study furthers our understanding of the genetic basis of human NOA and provides insights into FBXO43 and male infertility.